Position in NVO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,726,683
+$673,975 QoQ
Shares Held
56,877
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#316
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. NVO ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,933 | $38,301,401 | |
| 2 | ABBV |
AbbVie Inc.
|
100,846 | $25,376,887 | |
| 3 | JNJ |
Johnson & Johnson
|
83,035 | $21,088,398 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
76,862 | $9,710,745 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,774 | $8,580,459 | |
| 6 | AMGN |
Amgen Inc
|
11,139 | $4,033,654 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
56,877 | $2,726,683 | |
| 8 | NVS |
Novartis AG
|
15,640 | $2,451,100 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,726,683 | 56,877 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,052,708 | 55,856 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,224,371 | 43,718 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,544,771 | 45,860 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,087,609 | 44,735 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,344,994 | 48,171 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $4,139,196 | 48,119 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,118,650 | 51,387 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,317,280 | 51,263 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,575,107 | 51,208 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,384,728 | 42,385 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,711,897 | 40,817 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $3,262,492 | 20,160 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $3,068,378 | 19,281 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $1,748,186 | 12,917 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,333,248 | 13,382 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,519,236 | 13,634 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,490,957 | 13,426 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,370,992 | 12,241 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,119,380 | 11,659 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,045,449 | 12,480 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $786,589 | 11,667 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $791,470 | 11,331 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $572,242 | 8,242 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $453,449 | 6,925 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $388,651 | 6,456 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||